The EMPA-KIDNEY Collaborative Group
6  results:
Search for persons X
?
3

WCN23-0342 DETERMINANTS OF THE EFFECTS OF SGLT2i ON PROGRES..:

Staplin, N. ; Haynes, R. ; Herrington, W..
Kidney International Reports.  8 (2023)  3 - p. S472-S473 , 2023
 
?
6

Impact of primary kidney disease on the effects of empaglif..:

EMPA-KIDNEY Collaborative Group
https://openaccess.sgul.ac.uk/id/eprint/116462/1/1-s2.0-S2213858723003224-main.pdf.  , 2023
 
1-6